<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-028X</journal-id>
<journal-title><![CDATA[Vaccimonitor]]></journal-title>
<abbrev-journal-title><![CDATA[Vaccimonitor]]></abbrev-journal-title>
<issn>1025-028X</issn>
<publisher>
<publisher-name><![CDATA[Finlay Ediciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-028X2000000100004</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Validación de inmunoensayos cualitativos usados para evaluar la inmunogenicidad de vacunas]]></article-title>
<article-title xml:lang="en"><![CDATA[Validation of qualitative immunoassays used to evaluate the immunogenicity of vaccines]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[Rolando]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[Juan C]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Estrada]]></surname>
<given-names><![CDATA[Eric]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[Ana M.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferriol]]></surname>
<given-names><![CDATA[Xenia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[Rosa]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sotolongo]]></surname>
<given-names><![CDATA[Franklin]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Finlay  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2000</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2000</year>
</pub-date>
<volume>9</volume>
<numero>1</numero>
<fpage>17</fpage>
<lpage>20</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-028X2000000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-028X2000000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-028X2000000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Se realizó una revisión y actualización sobre la importancia de la validación de los inmunoensayos cualitativos usados para evaluar la inmunogenicidad de vacunas, sus principios y procedimientos. Se discutieron los principales parámetros empleados para evaluar estas técnicas. Se analizaron detalladamente los procedimientos para estudiar la sensibilidad, especificidad, valores predictivos positivos y negativos, valor de discriminación y zona gris. Se exponen nuestras experiencias.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[The importance of general principles and outline of procedures for the validation of qualitative immunoassays used to evaluate the immune response elicited by vaccines were analyzed. The main parameters used are discussed. Guidelines for the evaluation of the sensitivity, specificity, positive and negative predictive values, discrimination value and gray zone were carefully studied. Our experience is presented.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Validación]]></kwd>
<kwd lng="es"><![CDATA[vacunas]]></kwd>
<kwd lng="es"><![CDATA[inmunoensayos]]></kwd>
<kwd lng="en"><![CDATA[Validation]]></kwd>
<kwd lng="en"><![CDATA[vaccines]]></kwd>
<kwd lng="en"><![CDATA[immunoassays]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ARTICULOS ORIGINALES</b></font></p>     <p align="right">&nbsp;</p>     <p><font size="4" face="Verdana, Arial, Helvetica, sans-serif">Validaci&oacute;n de inmunoensayos cualitativos usados para evaluar la inmunogenicidad de vacunas.</font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana, Arial, Helvetica, sans-serif"><strong>Validation of qualitative immunoassays used to evaluate the immunogenicity of vaccines.</strong></font></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Rolando Ochoa, Juan C. Mart&iacute;nez, Eric Estrada, Ana M. Garc&iacute;a, Xenia Ferriol, Rosa Blanco, Franklin Sotolongo.</strong></font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Instituto Finlay. Centro de Investigaci&oacute;n-Producci&oacute;n de Vacunas y Sueros. Ciudad de La Habana, Cuba. E-mail: <a href="emailto:ochoa@finlay.edu.cu">ochoa@finlay.edu.cu</a>    <br> </font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>RESUMEN</strong></font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Se realiz&oacute; una revisi&oacute;n y actualizaci&oacute;n sobre la importancia de la validaci&oacute;n de los inmunoensayos cualitativos usados para    evaluar la inmunogenicidad de vacunas, sus principios y procedimientos. Se discutieron los principales par&aacute;metros    empleados para evaluar estas t&eacute;cnicas. Se analizaron detalladamente los procedimientos para estudiar la sensibilidad,   especificidad, valores predictivos positivos y negativos, valor de discriminaci&oacute;n y zona gris. Se exponen nuestras    experiencias.    <br> </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Palabras claves</strong>: Validaci&oacute;n, vacunas, inmunoensayos.</font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>ABSTRACT</strong></font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"> The importance of general principles and outline of procedures for the validation of qualitative immunoassays used to evaluate the    immune response elicited by vaccines were analyzed. The main parameters used are discussed. Guidelines for the evaluation of the    sensitivity, specificity, positive and negative predictive values, discrimination value and gray zone were carefully studied. Our    experience is presented.    <br>   </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Key words:</strong> Validation, vaccines, immunoassays</font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">texto completo en pdf</font></p>     <P  ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><B>REFERENCIAS</B> </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Broughton PMG, Bergonzi C, Lindstedt G, Loeber IG, Malan PG, Mathieu M, Pozet S. Guidelines for a user laboratory to evaluate and select a kit for its own use. Part 1. Quantitative tests. European Committee for Clinical Laboratory Standard, Vol. 3, No 3, 1986. </font>    <P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Broughton PMG, Bergonzi C, Lindstedt G, Loeber JG, Malan PG. Guidelines for the evaluation of diagnostic kits. Part 2. General principles and outline procedures for the evaluation of kits for qualitative tests. European Committee for Clinical Laboratory Standards, Vol. 3, No. 3, 1986. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Ochoa R. A new format ELISA for the detection of HBsAg. Biotecnolog&iacute;a Aplicada 1998;15:250-253. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Thielmann K. Principios de metodolog&iacute;a en bioqu&iacute;mica cl&iacute;nica. ed. Organismos: Instituto Cubano del Libro, 1973. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Cura E, Wendel S. Manual de procedimientos de control de calidad para los laboratorios de serolog&iacute;a de los Bancos de Sangre. Organizaci&oacute;n Panamericana de la Salud. Washington DC, 1994. </font>    <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Rodr&iacute;guez L, Balmaseda A, Bravo J, Trujillo J, Mart&iacute;nez L, Ochoa R et al. Validaci&oacute;n de un ultramicroELISA de detecci&oacute;n de anticuerpos contra el ant&iacute;geno de superficie de la hepatitis B. Rev Cubana Med. Trop. 1996;48(1):45-49. </font>    <p>&nbsp; </p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Broughton]]></surname>
<given-names><![CDATA[PMG]]></given-names>
</name>
<name>
<surname><![CDATA[Bergonzi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lindstedt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Loeber]]></surname>
<given-names><![CDATA[IG]]></given-names>
</name>
<name>
<surname><![CDATA[Malan]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
<name>
<surname><![CDATA[Mathieu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pozet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Guidelines for a user laboratory to evaluate and select a kit for its own use: Quantitative tests]]></article-title>
<source><![CDATA[European Committee for Clinical Laboratory Standard]]></source>
<year>1986</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Broughton]]></surname>
<given-names><![CDATA[PMG]]></given-names>
</name>
<name>
<surname><![CDATA[Bergonzi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lindstedt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Loeber]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Malan]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Guidelines for the evaluation of diagnostic kits: General principles and outline procedures for the evaluation of kits for qualitative tests]]></article-title>
<source><![CDATA[European Committee for Clinical Laboratory Standards]]></source>
<year>1986</year>
<volume>3</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A new format ELISA for the detection of HBsAg]]></article-title>
<source><![CDATA[Biotecnología Aplicada]]></source>
<year>1998</year>
<volume>15</volume>
<page-range>250-253</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thielmann]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Principios de metodología en bioquímica clínica]]></source>
<year>1973</year>
<publisher-name><![CDATA[Instituto Cubano del Libro]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cura]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Wendel]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Manual de procedimientos de control de calidad para los laboratorios de serología de los Bancos de Sangre]]></source>
<year>1994</year>
<publisher-loc><![CDATA[Washington^eDC DC]]></publisher-loc>
<publisher-name><![CDATA[Organización Panamericana de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Balmaseda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Validación de un ultramicroELISA de detección de anticuerpos contra el antígeno de superficie de la hepatitis B]]></article-title>
<source><![CDATA[Rev Cubana Med Trop]]></source>
<year>1996</year>
<volume>48</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45-49</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
